Sandbox: Gertrude: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 57: Line 57:


<ref name="AllmanDite2015">{{cite journal|last1=Allman|first1=Richard|last2=Dite|first2=Gillian S.|last3=Hopper|first3=John L.|last4=Gordon|first4=Ora|last5=Starlard-Davenport|first5=Athena|last6=Chlebowski|first6=Rowan|last7=Kooperberg|first7=Charles|title=SNPs and breast cancer risk prediction for African American and Hispanic women|journal=Breast Cancer Research and Treatment|volume=154|issue=3|year=2015|pages=583–589|issn=0167-6806|doi=10.1007/s10549-015-3641-7}}</ref>
<ref name="AllmanDite2015">{{cite journal|last1=Allman|first1=Richard|last2=Dite|first2=Gillian S.|last3=Hopper|first3=John L.|last4=Gordon|first4=Ora|last5=Starlard-Davenport|first5=Athena|last6=Chlebowski|first6=Rowan|last7=Kooperberg|first7=Charles|title=SNPs and breast cancer risk prediction for African American and Hispanic women|journal=Breast Cancer Research and Treatment|volume=154|issue=3|year=2015|pages=583–589|issn=0167-6806|doi=10.1007/s10549-015-3641-7}}</ref>
<ref name="KaklamaniHoffmann2013">{{cite journal|last1=Kaklamani|first1=Virginia G.|last2=Hoffmann|first2=Thomas J.|last3=Thornton|first3=Timothy A.|last4=Hayes|first4=Geoffrey|last5=Chlebowski|first5=Rowan|last6=Van Horn|first6=Linda|last7=Mantzoros|first7=Christos|title=Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women’s Health Initiative|journal=Breast Cancer Research and Treatment|volume=139|issue=2|year=2013|pages=461–468|issn=0167-6806|doi=10.1007/s10549-013-2546-6}}</ref>

Revision as of 21:31, 13 December 2018

BREAST CANCER

OVERVIEW

HISTOIRAL PERSPECTIBVE

CLASSIFICATION

PATHOPHYSIOLOGY

CAUSES

DIFFERENTIATING BREAST CANCER FROM OTHER DISEASES

EPIDEMIOLOGY AND DEMOGRAPHICS

RISK FACTORS

SCREENING

NATURAL HISTORY, COMPLICATIONS, AND PROGNOSIS

DIAGNOSIS

STAGING

HISTORY AND SYMPTOMS

PHYSICAL EXAMINATION

LABORATORY FINDINGS

MAMMOGRAPHY

MRI

ECHOCARDIOGRAPHY OR ULTRASOUND

OTHER IMAGING STUDIES

OTHER DIAGNOSTIC STUDIES

BIOPSY

TREATMENT

CHEMOTHERAPY

SURGERY

METASTATIC BREAST CANCER

BONE METASTATIC

PRIMARY PREVENTION

COST-EFFECTIVENESS OF THERAPY

FUTURE OR INVESTIGATIONAL THERAPIES


[1]

[2]

[3] [4]

  1. Nahleh, Zeina; Otoukesh, Salman; Mirshahidi, Hamid Reza; Nguyen, Anthony Loc; Nagaraj, Gayathri; Botrus, Gehan; Badri, Nabeel; Diab, Nabih; Alvarado, Andres; Sanchez, Luis A.; Dwivedi, Alok K. (2018). "Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics". Cancer Medicine. 7 (6): 2710–2717. doi:10.1002/cam4.1509. ISSN 2045-7634.
  2. Yedjou, Clement; Tchounwou, Paul; Payton, Marinelle; Miele, Lucio; Fonseca, Duber; Lowe, Leroy; Alo, Richard (2017). "Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States". International Journal of Environmental Research and Public Health. 14 (5): 486. doi:10.3390/ijerph14050486. ISSN 1660-4601.
  3. Allman, Richard; Dite, Gillian S.; Hopper, John L.; Gordon, Ora; Starlard-Davenport, Athena; Chlebowski, Rowan; Kooperberg, Charles (2015). "SNPs and breast cancer risk prediction for African American and Hispanic women". Breast Cancer Research and Treatment. 154 (3): 583–589. doi:10.1007/s10549-015-3641-7. ISSN 0167-6806.
  4. Kaklamani, Virginia G.; Hoffmann, Thomas J.; Thornton, Timothy A.; Hayes, Geoffrey; Chlebowski, Rowan; Van Horn, Linda; Mantzoros, Christos (2013). "Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative". Breast Cancer Research and Treatment. 139 (2): 461–468. doi:10.1007/s10549-013-2546-6. ISSN 0167-6806.